Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,162 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical and morphologic review of 60 hereditary renal tumors from 30 hereditary renal cell carcinoma syndrome patients: lessons from a contemporary single institution series.
Kennedy JM, Wang X, Plouffe KR, Dhanasekaran SM, Hafez K, Palapattu GS, Else T, Weizer AZ, Morgan TM, Spratt DE, Davenport MS, Chinnaiyan AM, Udager AM, Mehra R. Kennedy JM, et al. Among authors: mehra r. Med Oncol. 2019 Jul 22;36(9):74. doi: 10.1007/s12032-019-1297-6. Med Oncol. 2019. PMID: 31332543
Clinicopathological characterisation of renal cell carcinoma in young adults: a contemporary update and review of literature.
Abdulfatah E, Kennedy JM, Hafez K, Davenport MS, Xiao H, Weizer AZ, Palapattu GS, Morgan TM, Mannan R, Wang XM, Dhanasekaran SM, Kaffenberger SD, Spratt DE, Kunju L, Wu A, Lew M, Udager AM, Chinnaiyan AM, Mehra R. Abdulfatah E, et al. Among authors: mehra r. Histopathology. 2020 May;76(6):875-887. doi: 10.1111/his.14051. Epub 2020 Apr 27. Histopathology. 2020. PMID: 31872452 Free article. Review.
Impact of the MyProstateScore (MPS) Test on the Clinical Decision to Undergo Prostate Biopsy: Results From a Contemporary Academic Practice.
Lebastchi AH, Russell CM, Niknafs YS, Eyrich NW, Chopra Z, Botbyl R, Kabeer R, Osawa T, Siddiqui J, Siddiqui R, Davenport MS, Mehra R, Tomlins SA, Kunju LP, Chinnaiyan AM, Wei JT, Tosoian JJ, Morgan TM. Lebastchi AH, et al. Among authors: mehra r. Urology. 2020 Nov;145:204-210. doi: 10.1016/j.urology.2020.07.042. Epub 2020 Aug 8. Urology. 2020. PMID: 32777370
De novo neuroendocrine transdifferentiation in primary prostate cancer-a phenotype associated with advanced clinico-pathologic features and aggressive outcome.
Abdulfatah E, Reichert ZR, Davenport MS, Chinnaiyan AM, Dadhania V, Wang X, Mannan R, Kunju LP, Hollenbeck BK, Montgomery JS, Kaffenberger SD, Morgan TM, Alva AS, Palapattu GS, Vaishampayan UN, Alumkal JJ, Spratt DE, Udager AM, Mehra R. Abdulfatah E, et al. Among authors: mehra r. Med Oncol. 2021 Feb 14;38(3):26. doi: 10.1007/s12032-021-01473-2. Med Oncol. 2021. PMID: 33586037
A Phase I Trial of Neoadjuvant Stereotactic Body Radiotherapy Prior to Radical Prostatectomy for Locally Advanced Prostate Cancer.
Hammer L, Jiang R, Hearn J, Lashbrook J, Mitchell A, Daignault-Newton S, Dess RT, Jackson WC, Reichert Z, Alumkal JJ, Kaffenberger S, George A, Montgomery J, Salami SS, Morgan TM, Miller D, Wittman D, Hollenbeck B, Mehra R, Davenport MS, Sun Y, Schipper M, Palapattu G, Spratt DE. Hammer L, et al. Among authors: mehra r. Int J Radiat Oncol Biol Phys. 2023 Jan 1;115(1):132-141. doi: 10.1016/j.ijrobp.2022.07.016. Epub 2022 Jul 22. Int J Radiat Oncol Biol Phys. 2023. PMID: 35878714 Clinical Trial.
Metastatic prostate cancer diagnosed by fine-needle aspiration: Contemporary cytopathologic and biomarker assessment with clinical correlates.
Cantley RL, Wang X, Reichert ZR, Chinnaiyan AM, Mannan R, Cao X, Spratt DE, Vaishampayan UN, Alumkal JJ, Morgan TM, Palapattu G, Davenport MS, Pantanowitz L, Mehra R. Cantley RL, et al. Among authors: mehra r. Cancer Cytopathol. 2023 Feb;131(2):117-135. doi: 10.1002/cncy.22652. Epub 2022 Oct 20. Cancer Cytopathol. 2023. PMID: 36264673 Free PMC article. Review.
Extragonadal germ cell tumors: A clinicopathologic study with emphasis on molecular features, clinical outcomes and associated secondary malignancies.
Abdulfatah E, Brown NA, Davenport MS, Reichert ZR, Camelo-Piragua S, Heider A, Huang T, Vaishampayan UN, Skala SL, Montgomery JS, Chinnaiyan AM, Kaffenberger SD, Bawa P, Shao L, Mehra R. Abdulfatah E, et al. Among authors: mehra r. Hum Pathol. 2024 Jun;148:41-50. doi: 10.1016/j.humpath.2024.04.015. Epub 2024 Apr 30. Hum Pathol. 2024. PMID: 38697270
1,162 results